SNI Blog

SNI Blog

Pituitary Tumors: Diagnosis and Management

Erin Kieper

Erin Kieper
Program Development Manager, Swedish Radiosurgery Center

The Swedish Pituitary Center at the Swedish Neuroscience Institute is one of the country’s largest centers for treating disorders of the pituitary gland – including pituitary tumors. The center brings together endocrinologists, neurosurgeons and radiation oncologists to offer a comprehensive, multidisciplinary approach to the diagnosis and treatment of these tumors.
 
Tumors in the pituitary gland are quite common and many of them are so small they may go undetected throughout life. Although 99 percent of pituitary tumors are benign, the associated symptoms can be
debilitating, especially with hormone-secreting tumors. Regardless of the type of tumor, individuals with pituitary tumors may experience headaches, blurred vision, impotence/infertility, and mood changes.

Update from essential tremor (ET) forum

Peggy Shortt, MN, ARNP

Peggy Shortt, MN, ARNP
Manager, Swedish Deep Brain Stimulation Program

On Saturday, January 25, essential tremor (ET) patients in the community gathered for a symposium on the diagnosis, medical management and interventions for the treatment of tremor.  Swedish planned the event in collaboration with the International Essential Tremor Foundation.  Over 120 people in our community gathered to learn and share their stories. Dr. Gwinn discussed the MR Focused Ultrasound study, Gamma Knife, and Deep Brain Stimulation as treatment options for essential tremor.  Patients also shared their experiences with DBS.  It was a great event!

Debilitating Facial Pain May Be Trigeminal Neuralgia

Dean Hamilton, ARNP

Dean Hamilton, ARNP
ARNP, Swedish Cerebrovascular Center

All pain can be frightening, but when patients describe sharp, electric-type pain in their face, the cause may be Trigeminal Neuralgia, a treatable pain syndrome manifesting as unilateral facial pain that can be severe in intensity. The pain occurs in one or more distributions of the trigeminal nerve. The pain usually lasts for several seconds to several minutes followed by periods of being pain free. Trigeminal neuralgia pain can be triggered by sensory stimuli to the face including talking, brushing teeth, eating, and touching the face. In some cases, there is no trigger. The annual incidence of trigeminal neuralgia is approximately 4 in 100,000. The initial workup for trigeminal neuralgia may include an MRI of the brain to rule out brain tumor or MS plaques.

In many cases, trigeminal neuralgia is caused by compression of the facial nerve most commonly by the superior cerebellar artery or the anterior inferior cerebellar artery, although trigeminal neuralgia can be due to compression by a persistent permanent trigeminal artery or odioectatic basilar artery. Other causes of Trigeminal Neuralgia can include demyelinating disease (such as multiple sclerosis) and tumor. In some cases, the cause of Trigeminal Neuralgia is  ...

January 25 essential tremor seminar

Tami Bloom

Tami Bloom
Business Development Specialist, Swedish Neuroscience Institute

If you or someone you care about shakes a lot—it could be essential tremor (ET) or another movement disorder. Essential tremor is a disorder affecting approximately 10 million Americans. This progressive neurological condition can cause the hands, head, voice, legs or trunk of the body to shake and can cause significant disability. It is often confused with Parkinson’s disease or dystonia. Because of stereotypes and lack of awareness, many people with ET never seek medical care, though most would benefit from treatment.
 
In an upcoming event, Dr. Ryder Gwinn will explain the causes, diagnosis,  research and treatment options for essential tremor.
 
Date: Saturday, January 25
Time: Check-in 9:30am/Program 10am-Noon
Location: Bellevue Hilton, 300 112 Ave SE, Bellevue, WA
 
There is no charge for the event but please note, parking in the Bellevue Hilton lot is $5.

Registration is required - call 888-387-3667 or visit www.essentialtremor.org/seminars

 

 
 

New Brain Stimulator Approved to Treat Epilepsy

Ryder P. Gwinn, MD

On November 14th, 2013 the FDA gave its approval for an implanted brain stimulator to treat patients with medically refractory epilepsy. Epilepsy is one of the most common neurological disorders affecting nearly 1 in 100 Americans. This device has been under investigation for 10 years at the Swedish Neuroscience Institute (SNI) Epilepsy Center.

As principal investigator for the trial, I led  a team including Dr. Michael Doherty, Dr. Lisa Caylor and Dr. Alan Haltiner, along with the research department at Swedish to investigate the safety and effectiveness of the device through pivotal trials. The results showed that the responsive neurostimulator system (RNS) made by NeuroPace was indeed effective in treating patients with drug resistant seizures.

Why is this so significant? This device represents the first new non-medication treatment for seizures proven to be effective since 1997, and gives new hope to patients whose lives have been put on hold due to seizures. ...

Brain Aneurysm Awareness: Spreading the Word

Tami Bloom

Tami Bloom
Business Development Specialist, Swedish Neuroscience Institute

September is National Brain Aneurysm Awareness Month and across the country, those affected by various forms of the disease raise awareness through fundraising and visibility events. Bringing a voice to the disease may seem daunting in a sea of awareness ribbons and weekend community walks—but  Swedish had the opportunity to focus a spotlight on Seattle as host for the Brain Aneurysm Foundation’s Annual Symposium. This Massachusetts-based organization is the nation’s only not-for-profit profit organization solely dedicated to providing critical awareness, education, support and research funding to reduce the incidence of brain aneurysms. Swedish Neuroscience Institute physicians teamed up with other elite physicians from across the country and others in the medical community, in addition to volunteers and Brain Aneurysm Foundation members to learn more about advances in research for the disease.

One unique component to this important event was the attendance of members of the Swedish Cerebrovascular Support Group. The group, established in 2012, brings together patients, family members and caregivers to share their experiences, with the goal of alleviating fears and concerns through education and group discussions...

Life-saving technology and getting the word out about radiosurgery

Erin Kieper

Erin Kieper
Program Development Manager, Swedish Radiosurgery Center

Twice last week I received phone calls from grateful family members thanking us for taking care of their loved ones when treatment options were dwindling. One patient is now 4 years past his CyberKnife treatment for inoperable lung cancer and is going strong and living life to the fullest. The other patient was recently treated and is feeling great and planning a European vacation. Both families are extremely appreciative for the care they received but both voiced frustration that they stumbled upon this treatment option by chance and that we need to do a better job of publicizing the radiosurgery modalities. As the person receiving these calls, I am thrilled to hear how our center has positively impacted so many lives but struggle with how to get the word out to those who may benefit from radiosurgery in the future. So with our patients’ stories fresh in my mind, here is an introduction to radiosurgery.

Stereotactic radiosurgery is targeted radiation therapy delivered to nearly any body part with precision while utilizing real time image guidance. The ....

Results 1-7 of 64

Top Authors

Karen Pabillon
John W Henson IV

John W Henson IV
Director, Neurology

Peggy Shortt, MN, ARNP

Peggy Shortt, MN, ARNP
Manager, Swedish Deep Brain Stimulation Program

Erin Kieper

Erin Kieper
Program Development Manager, Swedish Radiosurgery Center